Cargando…

Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review

S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Jia, Rui, Li, Junyuan, Sun, Jinfeng, Yang, Zhihao, Hong, Weiguo, Lu, Zhenyu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113621/
https://www.ncbi.nlm.nih.gov/pubmed/37089937
http://dx.doi.org/10.3389/fphar.2023.1122008
Descripción
Sumario:S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and numerous Skp2 inhibiting compounds have been identified. In this review, we would describe the structural features of Skp2, introduce the ubiquitination function of SCF(Skp2), and summarize the diverse natural and synthetic Skp2 inhibiting compounds reported to date. The IC(50) data of the Skp2 inhibitors or inhibiting compounds in various kinds of tumors at cellular levels implied that the cancer type, stage and pathological mechanisms should be taken into consideration when selecting Skp2-inhibiting compound for cancer treatment.